← Evidence map

ArticleOncogene2016

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.

L Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

221 papers cite itlatest 60 shown

2016
…
2017
2018
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 26364599